Literature DB >> 19956193

Genetics: Prostate cancer risk stratification by genotype and PSA.

Jonathan L Wright, Daniel W Lin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956193     DOI: 10.1038/nrurol.2009.229

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Shaking the tree: mapping complex disease genes with linkage disequilibrium.

Authors:  Lyle J Palmer; Lon R Cardon
Journal:  Lancet       Date:  2005-10-01       Impact factor: 79.321

2.  Ancestry estimation and correction for population stratification in molecular epidemiologic association studies.

Authors:  Jill S Barnholtz-Sloan; Brian McEvoy; Mark D Shriver; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

3.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

4.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Authors:  Gerrit Draisma; Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Elisabeth Wever; Roman Gulati; Eric Feuer; Harry de Koning
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

6.  Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.

Authors:  Stacy Loeb; H Ballentine Carter; Patrick C Walsh; William B Isaacs; Anna Kettermann; Toshiko Tanaka; Luigi Ferrucci; E Jeffrey Metter
Journal:  J Urol       Date:  2009-05-17       Impact factor: 7.450

Review 7.  New and novel markers for prostate cancer detection.

Authors:  Michael C Risk; Daniel W Lin
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

Review 8.  Prostate cancer genomics: towards a new understanding.

Authors:  John S Witte
Journal:  Nat Rev Genet       Date:  2008-12-23       Impact factor: 53.242

9.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Authors:  H Gilbert Welch; Peter C Albertsen
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506

  9 in total
  1 in total

1.  P4 medicine: how systems medicine will transform the healthcare sector and society.

Authors:  Mauricio Flores; Gustavo Glusman; Kristin Brogaard; Nathan D Price; Leroy Hood
Journal:  Per Med       Date:  2013       Impact factor: 2.512

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.